• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Translational Development Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8/14/25 4:20:52 PM ET
    $TDAC
    Get the next $TDAC alert in real time by email
    false 0001926599 00-0000000 0001926599 2025-08-08 2025-08-08 0001926599 TDACU:UnitsEachConsistingOfOneClassaOrdinaryShare0.0001ParValueAndOnehalfOfOneRedeemableWarrantMember 2025-08-08 2025-08-08 0001926599 TDACU:ClassaOrdinaryShares0.0001ParValuePerShareMember 2025-08-08 2025-08-08 0001926599 TDACU:RedeemableWarrantsIncludedAsPartOfUnitsEachWholeWarrantExercisableForOneClassaOrdinaryShareAtExercisePriceOf11.50Member 2025-08-08 2025-08-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 OR Section 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): August 8, 2025

     

    TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   001-42451   N/A
    (State or other jurisdiction of
    incorporation or organization)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    52 E. 83rd Street,

    New York, New York

      10028
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code (917) 979-3072

     

    Not Applicable

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading
    Symbol(s)
      Name of each exchange
    on which registered
    Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant   TDACU   The Nasdaq Stock Market LLC
    Class A ordinary shares, $0.0001 par value per share   TDAC   The Nasdaq Stock Market LLC
    Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   TDACW   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

     

    Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

     

    The information relating to the Note included in Item 8.01 is incorporated by reference in this item to the extent required herein.

     

    Item 8.01. Other Events.

     

    On August 8, 2025, TDAC Partners LLC (“Sponsor”) agreed to loan to Translational Development Acquisition Corp. (the “Company”) up to an aggregate of $2,000,000 for working capital purposes. The loan is evidenced by a promissory note (the “Note”) which is non-interest bearing and repayable on the earlier of (i) the date by which the Company has to complete a merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses or entities to the Company’s Amended and Restated Memorandum of Association (as it may be amended from time to time) (a “Business Combination”), and (ii) the effective date of a Business Combination (such earlier date of (i) and (ii), the “Maturity Date”).

     

    If the Company does not consummate a Business Combination, the Note will not be repaid and all amounts owed under the Note will be forgiven except to the extent that the Company has funds available to it outside of its trust account established in connection with the initial public offering (the “Trust Account”). The issuance of the Note was exempt pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.

     

    The foregoing summary of the Note is qualified in its entirety by reference to the text of the Note, which is filed as an exhibit hereto and incorporated by reference herein.

     

     

     

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.
       
      The following exhibits are being filed herewith:
       
    10.1 Promissory Note, dated August 8, 2025.
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: August 14, 2025

     

    TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.  
       
    By: /s/ Michael B. Hoffman  
    Name: Michael B. Hoffman  
    Title: Chief Executive Officer  

     

     

     

    Get the next $TDAC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TDAC

    DatePrice TargetRatingAnalyst
    9/21/2021$16.00Outperform
    Northland Capital Markets
    More analyst ratings

    $TDAC
    SEC Filings

    View All

    Translational Development Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - Translational Development Acquisition Corp. (0001926599) (Filer)

    8/14/25 4:20:52 PM ET
    $TDAC

    SEC Form 10-Q filed by Translational Development Acquisition Corp.

    10-Q - Translational Development Acquisition Corp. (0001926599) (Filer)

    8/14/25 4:08:05 PM ET
    $TDAC

    Amendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.

    SCHEDULE 13G/A - Translational Development Acquisition Corp. (0001926599) (Subject)

    7/31/25 4:56:09 PM ET
    $TDAC

    $TDAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Jarratt Christopher Kenneth

    3 - Translational Development Acquisition Corp. (0001926599) (Issuer)

    1/6/25 4:05:09 PM ET
    $TDAC

    SEC Form 3 filed by new insider Keith Curtis T

    3 - Translational Development Acquisition Corp. (0001926599) (Issuer)

    12/20/24 6:59:32 PM ET
    $TDAC

    SEC Form 3 filed by new insider Tdac Partners Llc

    3 - Translational Development Acquisition Corp. (0001926599) (Issuer)

    12/20/24 6:58:51 PM ET
    $TDAC

    $TDAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lottery.com to Present at the 10th Annual Gateway Conference on September 9, 2021

    AUSTIN, TX / ACCESSWIRE / September 2, 2021 / AutoLotto, Inc. ("Lottery.com"), a leading technology company that is transforming how, where and when the lottery is played, announced today that its management will participate in the virtual 10th Annual Gateway ConferenceLottery.com's management is scheduled to present on Thursday, September 9th at 8:00 a.m. Pacific time, with one-on-one meetings to be held throughout the day. The presentation will be webcast live and available for replay here.To receive additional information, request an invitation, or schedule a one-on-one meeting, please email [email protected] Feb. 21, 2021, Lottery.com entered into a definitive agreement with Tr

    9/2/21 4:15:00 PM ET
    $TDAC

    10th Annual Gateway Conference to Virtually Showcase Leading Companies on September 8-9, 2021

    Executives from a Range of Industries to Present to 500+ Investors and AnalystsNEWPORT BEACH, CA / ACCESSWIRE / August 24, 2021 / The Gateway Conference is back for its 10th year and will showcase leading public and private companies virtually on September 8th and 9th.Attendees will have the opportunity to discover and learn about a select group of compelling companies across a wide range of industries, including consumer & wellness, financials, internet & business services, industrials, technology & electric vehicles, and SPACs.The invitation-only conference provides investors and analysts a unique opportunity to gain valuable insights during two days of presentations and one-on-one meeting

    8/24/21 1:30:00 PM ET
    $AROC
    $AUTO
    $AWRE
    Natural Gas Distribution
    Utilities
    Business Services
    Consumer Discretionary

    Trident Acquisitions Corp. Files 10-Q and is in Compliance with Nasdaq Reporting Rules

    NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- Trident Acquisitions Corp. (the "Company") today announced that it has filed the Form 10-Q for the period ended March 31, 2021 with the Securities and Exchange Commission ("SEC"), thereby bringing the Company into compliance with Nasdaq listing rules for financial reporting with the SEC. With this filing completed, the Company is squarely focused on expeditiously completing its previously announced business combination with AutoLotto. Inc., doing business as Lottery.com, with priority given to filing the Form S-4.   The Nasdaq Hearings Panel will no longer need to consider the Form 10-Q deficiency at the hearing to be held in connection with the

    6/30/21 7:00:00 AM ET
    $TDAC

    $TDAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital Markets initiated coverage on Trident Acquisitions with a new price target

    Northland Capital Markets initiated coverage of Trident Acquisitions with a rating of Outperform and set a new price target of $16.00

    9/21/21 8:09:12 AM ET
    $TDAC

    $TDAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed

    SC 13G - Trident Acquisitions Corp. (0001673481) (Subject)

    2/12/21 4:30:21 PM ET
    $TDAC